1. Home
  2. LSBK vs ARMP Comparison

LSBK vs ARMP Comparison

Compare LSBK & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lake Shore Bancorp Inc.

LSBK

Lake Shore Bancorp Inc.

HOLD

Current Price

$14.76

Market Cap

110.0M

Sector

Finance

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$6.31

Market Cap

125.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSBK
ARMP
Founded
1891
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.0M
125.7M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
LSBK
ARMP
Price
$14.76
$6.31
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
11.5K
45.6K
Earning Date
01-23-2026
11-12-2025
Dividend Yield
2.44%
N/A
EPS Growth
105.28
N/A
EPS
1.21
N/A
Revenue
$27,774,000.00
$5,054,000.00
Revenue This Year
N/A
$4.48
Revenue Next Year
N/A
N/A
P/E Ratio
$12.24
N/A
Revenue Growth
9.61
N/A
52 Week Low
$11.50
$0.90
52 Week High
$16.95
$16.34

Technical Indicators

Market Signals
Indicator
LSBK
ARMP
Relative Strength Index (RSI) 55.00 56.96
Support Level $14.53 $6.09
Resistance Level $14.98 $6.54
Average True Range (ATR) 0.21 0.53
MACD -0.06 0.04
Stochastic Oscillator 34.85 100.00

Price Performance

Historical Comparison
LSBK
ARMP

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: